These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain. Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for the treatment of tremor. Mittal SO; Pandey S J Neurol Sci; 2022 Apr; 435():120203. PubMed ID: 35227926 [TBL] [Abstract][Full Text] [Related]
10. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Friedman JH Parkinsonism Relat Disord; 2020 Oct; 79():60-64. PubMed ID: 32871538 [TBL] [Abstract][Full Text] [Related]
11. Rare tremors and tremors occurring in other neurological disorders. Erro R; Reich SG J Neurol Sci; 2022 Apr; 435():120200. PubMed ID: 35220114 [TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005 [TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation for the treatment of tremor. Chandra V; Hilliard JD; Foote KD J Neurol Sci; 2022 Apr; 435():120190. PubMed ID: 35299121 [TBL] [Abstract][Full Text] [Related]
14. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920 [TBL] [Abstract][Full Text] [Related]
15. The MDS consensus tremor classification: The best way to classify patients with tremor at present. Latorre A; Hallett M; Deuschl G; Bhatia KP J Neurol Sci; 2022 Apr; 435():120191. PubMed ID: 35247714 [TBL] [Abstract][Full Text] [Related]
16. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]
18. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs. Mandrioli R; Protti M; Mercolini L Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591 [TBL] [Abstract][Full Text] [Related]
19. Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database. Marengoni A; Onder G; Degli Esposti L; Russo P; Sangiorgi D; Buda S; Fini M; Marchionni N; Bonassi S; Mammarella F; Marrocco W; Pozzi G; Palmer K; Monaco A; Pecorelli S; Pani L; J Clin Psychiatry; 2016 Dec; 77(12):1712-1718. PubMed ID: 28086009 [TBL] [Abstract][Full Text] [Related]
20. Essential tremor: Clinical perspectives and pathophysiology. Pan MK; Kuo SH J Neurol Sci; 2022 Apr; 435():120198. PubMed ID: 35299120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]